CAS 885101-89-3
:3-{4-[(3-Phenoxybenzyl)amino]phenyl}propanoic acid
- Benzenepropanoic acid, 4-[[(3-phenoxyphenyl)methyl]amino]-
- Gw9508
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
3-(4-{[(3-Phenoxyphenyl)methyl]amino}phenyl)propanoic acid
CAS:3-(4-{[(3-Phenoxyphenyl)methyl]amino}phenyl)propanoic acidFormula:C22H21NO3Purity:98%Molecular weight:347.40704GW9508
CAS:3-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acidFormula:C22H21NO3Purity:98%Molecular weight:347.41GW9508
CAS:GW9508(GW 9508) is a potent and selective agonist for FFA1 (GPR40), stimulates insulin secretion in a glucose-sensitive manner.Formula:C22H21NO3Purity:97.89% - 99.19%Color and Shape:White SolidMolecular weight:347.413-(4-((3-Phenoxybenzyl)amino)phenyl)propanoic acid
CAS:Formula:C22H21NO3Purity:98%Color and Shape:SolidMolecular weight:347.414GW9508
CAS:Controlled ProductApplications GW9508 is a GPR40 full agonist, used to regulate glucose in rats. Can be applied to the treatment of diabetes type 2. GPR120 selective and potent agonist also used in the treatment of diabetes type 2 due to GPR120’s ability to mediate GLP-1 secretion, insulin sensitization and anti-obesity effects.
References Luo, J. et al.: PLoS One., 7, 46300 (2012); Shimpukade, B. et al.: J. Med. Chem., 55, 4511 (2012);Formula:C22H21NO3Color and Shape:NeatMolecular weight:347.41GPR40 Agonist
CAS:GW9508 is a GPR40 agonist that activates the receptor and increases cytosolic calcium. It has been shown to increase glucose uptake in pluripotent cells and decrease glucose production by decreasing the activity of gluconeogenic enzymes. GW9508 is also a potential drug for diabetes as it can stimulate insulin secretion. This drug has been shown to activate toll-like receptors, which are proteins that sense microbial infections and regulate inflammatory responses. It may also act as an agonist for other receptors such as DPP-IV inhibitors or response elements.
Formula:C22H21NO3Purity:Min. 95%Molecular weight:347.41 g/mol






